INVO Fertility (IVF) Share-based Compensation (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,891.20% |
| Jun 30, 2025 | -83.19% |
| Mar 31, 2025 | 133.77% |
| Dec 31, 2024 | -200.00% |
| Sep 30, 2024 | 342,880.33% |
| Jun 30, 2024 | -33.70% |
| Mar 31, 2024 | 100.01% |
| Dec 31, 2023 | -193.44% |
| Sep 30, 2023 | 908.41% |
| Jun 30, 2023 | -125.06% |
| Mar 31, 2023 | -73.04% |
| Dec 31, 2022 | 1,420.37% |
| Sep 30, 2022 | 179.53% |
| Jun 30, 2022 | -123.32% |
| Mar 31, 2022 | 154.13% |
| Dec 31, 2021 | -1,000.50% |
| Sep 30, 2021 | -77.11% |
| Jun 30, 2021 | 2.01% |
| Mar 31, 2021 | 30.37% |
| Dec 31, 2020 | 11.27% |
| Sep 30, 2020 | 371.84% |
| Jun 30, 2020 | -85.58% |
| Mar 31, 2020 | 446.63% |
| Jun 30, 2018 | 759.72% |
| Mar 31, 2018 | 129.37% |
| Dec 31, 2017 | 177.04% |
| Sep 30, 2017 | -40.56% |
| Jun 30, 2017 | -18.81% |
| Sep 30, 2013 | -71.46% |
| Jun 30, 2013 | -41.60% |
| Mar 31, 2013 | 268.30% |